Short Interest in Esperion Therapeutics, Inc. (NASDAQ:ESPR) Decreases By 6.6%
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) saw a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 31,250,000 shares, a decline of 6.6% from the October 31st total of 33,460,000 shares. Based on an average daily volume of 3,820,000 shares, the days-to-cover ratio […]
More Stories
Honeywell International’s (HON) Sector Perform Rating Reiterated at Royal Bank of Canada
Royal Bank of Canada reissued their sector perform rating on shares of Honeywell International (NASDAQ:HON – Free Report) in a...
Eastman Chemical (NYSE:EMN) Upgraded at StockNews.com
StockNews.com upgraded shares of Eastman Chemical (NYSE:EMN – Free Report) from a hold rating to a buy rating in a...
UBS Group Upgrades CenterPoint Energy (NYSE:CNP) to “Buy”
UBS Group upgraded shares of CenterPoint Energy (NYSE:CNP – Free Report) from a neutral rating to a buy rating in...
Regions Financial (NYSE:RF) Price Target Raised to $29.00
Regions Financial (NYSE:RF – Free Report) had its target price boosted by Piper Sandler from $25.00 to $29.00 in a...
Nevro (NYSE:NVRO) Now Covered by Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a research report report published...
REX American Resources Reports Strong Fiscal Q3 2024 Results
On December 3, 2024, REX American Resources Corporation (NYSE: REX) released its financial results for the fiscal third quarter of...